Alliqua BioMedical, Inc. Announces the Publication of Results From a Biovance(R) Use Registry Study in WOUNDS
Alliqua BioMedical, Inc. Appoints Nino Pionati as Chief Strategy and Marketing Officer
Alliqua BioMedical, Inc. Announces Closing of Celleration, Inc. Acquisition
Alliqua BioMedical, Inc. Reports First Quarter Financial Results
Alliqua BioMedical, Inc. to Attend Craig-Hallum Institutional Investor Conference
Alliqua Biomedical Announces Expansion to Its Exclusive Licensing Agreement with Celgene Cellular Therapeutics
Alliqua BioMedical Presents at the Spring 2015 Symposium on Advanced Wound Care
Alliqua BioMedical, Inc. to Announce First Quarter of Fiscal Year 2015 Results on May 14th
Alliqua BioMedical, Inc. Announces Closing of $34.5 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
